Business Description
Retension Pharmaceuticals Inc. is a clinical-stage company working to develop new treatments for high blood pressure and heart-related conditions. Its lead drug candidate, RTN-001, is a pill that works by supporting the body's natural blood pressure regulation process. Founded in 2023 and based in Falls Church, Virginia, the company is focused entirely on bringing these treatments to patients.
